Positron emission tomography and radioimmunotargeting - General aspects

Acta Oncologica

Volumn 38, Issue 3, 1999, Pages 335-341

  Lundqvist, Hans ^a   Lubberink, Mark ^b   Tolmachev, Vladimir ^b   Lövqvist, Anna ^b   Sundin, Anders ^b   Beshara, Soheir ^b   Bruskin, Alexander ^b   Carlsson, Jörgen ^b   Westlin, Jan Erik ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROMINE; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INDIUM; IRON 52; PENTETREOTIDE; PENTETREOTIDE IN 111; RADIOACTIVE IODINE; RADIOISOTOPE; YTTRIUM;

ARTICLE; CANCER LOCALIZATION; DRUG HALF LIFE; DRUG TARGETING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NECK METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOTHERAPY; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BROMINE RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FORECASTING; HALF-LIFE; HUMANS; INDIUM RADIOISOTOPES; IRON RADIOISOTOPES; PILOT PROJECTS; RADIOIMMUNOTHERAPY; STRONTIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033040568     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431410     Document Type: Article

References (34)

1. 1. Handbook of targeted delivery of imaging agents. Torchilini VP, ed. Boca Raton, FL: CRC Press, 1995.
2. 2. Gaze MN. The current status of targeted radiotherapy in clinical practice. Phys Med Biol 1996; 41: 1895-903.
3. 3. Zweit J. Radionuclides and carrier molecules for therapy. Phys Med Biol 1996; 41: 1905-14.
4. 4. Carlsson J, Gedda L, Grönvik C, et al. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor. Int J Radiat Oncol Biol Phys 1994; 30: 105-15.
5. 5. Wängberg B, Nilsson O, Johansson V, et al. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumors. Oncologist 1997; 2: 50-8.
6. 6. Watson JD. Images of the working brain: understanding human brain function with positron emission tomography. J Neurosci Methods 1997; 74: 245-56.
7. 7. Beanlands R. Positron emission tomography in cardiovascular disease. Can J Cardiol 1996; 12: 875-83.
8. 8. Rubin RH, Fishman AJ. Positron emission tomography in drug development. Q J Nucl Med 1997; 41: 171-5.
9. 9. Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med 1097; 24: 1301-27.
10. 76Br by a low-energy cyclotron. Appl Radiat Isot 1998; 49: 1537-40.
11. 61Cu from a natural nickel target. Appl Radiat Isot 1997; 49: 79-81.
12. 12. Tolmachev V, Lundqvist H. Rapid separation of Gallium from Zinc targets by thermal diffusion. Appl Radiat Isot 1996; 47: 297-9.
13. 13. Tolmachev T, Lundqvist H, Einarsson L. Diffusion based separation methods: dry distillation of zinc, cadmium and mercury isotopes from irradiated targets. Appl Radiat Isot 1997; 48: 565-9.
14. 110In from enriched Cd targets by thermal diffusion. Appl Radiat Isot 1995; 46: 859-63.
15. [ipq]2Fe for additional marrow ablation before bone marrow transplantation. Blood 1993; 81: 3435-9.
16. 16. O'Donoghue JA, Wheldon TE. Targeted radiotherapy using Auger electron emitters. Phys Med Biol 1996; 41: 1973-92.
17. 17. Herzog H, Rösch F, Stöcklin G, et al. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculations of analogous yttrium-90 radiotherapeutics. J Nucl Med 1993; 34: 2222-6.
18. 18. Rösch F, Herzog H, Plag C, et al. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur J Nucl Med 1996; 23: 958-66.
19. 19. Dghighian F, Pentlow KS, Larson SM, et al. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma. Eur J Nucl Med 1993; 20: 402-9.
20. 20. Flower MA, Al-Saadi A, Harmer CL, McCready VR, Ott RJ. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy. Eur J Nucl Med 1994; 21: 531-6.
21. 21. Pentlow KS, Graham MC, Lambrecht RM, et al. Quantitative imaging of iodine-124 with PET. J Nucl Med 1996; 37: 1557-62.
22. 22. Zweit J, Flower M, Brown A, et al. Iodine 120-mIBG: production and NCA labelling of a new PET radiotracer. J Nucl Med 1996; 37: 191.
23. 76Br for radioimmuno-PET [dissertation]. Uppsala: Uppsala University, 1996.
24. 18F)fluorodeoxyglucose, and (11C)methionine. J Nucl Med 1997; 38: 1029-35.
25. 25. Lövqvist A, Sundin A, Ahlström M, Carlsson J, Lundqvist H. Pharmacokinetics and experimental PET imaging of a Bromine-76-labeled monoclonal anti-CEA antibody. J Nucl Med 1997; 38: 395-401.
26. 26. Rösch F, Blessing G, Linse KH, et al. Production of the positron-emitting strontium isotope Sr-83 and PET phantom measurements preparatory to the evaluation of Sr-89 pharmacokinetics and dosimetry. J Nucl Med 1996; 37: 166.
27. 27. Stabin MG, Kooij PPM, Bakker WH, et al. Radiation dosimetry for indium-111-pentreotide. J Nucl Med 1997; 38: 1919-22.
28. 59Fe-labelled iron(III) hydroxide-sucrose complex in anaemic patients. Br J Haematol. In press.
29. 29. Sgouros G. Bone marrow dosinietry for radioimmunotherapy: theoretical calculations. J Nucl Med 1993; 34: 689-94.
30. 30. Coleman ER, Tesar RD. Clinical PET: are we ready? J Nucl Med 1997; 38: 16N.
31. 31. Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun 1996; 17: 758-66.
32. 32. Dahlbom M, MacDonald LR, Eriksson L, et al. Performance of a YSO LSO Phoswich detector for use in a PET/SPECT system. IEEE Trans Nucl Sci 1997; 44: 1114-9.
33. 33. Dale LB, Young H, Bloomfield PM, et al. ECAT ART - A continuously rotating PET camera: performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department. Eur J Nucl Med 1997; 24: 8-15.
34. 34. Shao Y, Cherry SR, Farahani K, et al. Development of a PET detector system compatible with MR1. NMR systems. IEEE Trans Nucl Sci 1997; 44: 1167-71.